Repare Therapeutics Inc.

RPTX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$85-$94-$29-$107
Dep. & Amort.$2$2$2$1
Deferred Tax$0$0$4$0
Stock-Based Comp.$23$25$20$13
Change in WC-$14-$55$8$5
Other Non-Cash-$3-$5-$4$2
Operating Cash Flow-$76-$127$0-$86
Investing Activities
PP&E Inv.$0-$2-$1-$2
Net Acquisitions$0$0$175$0
Inv. Purchases-$133-$179-$257-$7
Inv. Sales/Matur.$183$259$81$7
Other Inv. Act.$0$0-$175$0
Investing Cash Flow$49$78-$176-$2
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$1$1$1$94
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$1
Financing Cash Flow$1$1$1$96
Forex Effect-$0$0-$0-$0
Net Chg. in Cash-$27-$48-$175$8
Supplemental Information
Beg. Cash$111$160$334$326
End Cash$85$111$160$334
Free Cash Flow-$76-$129-$0-$87